EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Hélène Schoemans(KU Leuven), Steven Z. Pavletic(National Institutes of Health)
Cited by 479
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Secondary solid cancer screening following hematopoietic cell transplantation
|Bone Marrow Transplantation|2015|185
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
|Bone Marrow Transplantation|2019|119
Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern era
|Haematologica|2017|109